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Abstract: Full dilatation caesarean sections (CS) have increased risk of uterine extensions, which leads
to cervical trauma that has been associated with an increased risk of spontaneous preterm birth (sPTB)
in a subsequent pregnancy. The aim of this study was to determine if CS at full dilatation increased
the risk of sPTB in a subsequent pregnancy in our unit. A historical cohort study was performed
on women delivered by emergency CS between 2008–2015 (n = 5808) in a university hospital who
had a subsequent pregnancy in this time frame (n = 1557). Women were classified into two exposure
groups; those who were 6–9 cm and those fully dilated at index CS. The reference group was CS at
0–5 cm dilated. The primary outcome was sPTB < 37 weeks’ gestation. CS at 6–9 cm or fully dilated
did not significantly increase the odds of sPTB in a subsequent pregnancy (aOR 1.64, 95% CI: 0.83–3.28,
p = 0.158; aOR 1.86, 95% CI: 0.91–3.83; p = 0.090, respectively). However, a short interpregnancy
interval of <1 year significantly increased the odds of sPTB in a subsequent pregnancy (aOR 3.10,
95% CI: 1.71–5.61). This study has found a short interpregnancy interval following a CS conferred
a higher risk of sPTB than full dilatation CS. This finding highlights postnatal contraception and
increased surveillance of women with short interpregnancy interval post CS as possible interventions
to reduce sPTB.
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1. Introduction
In 2017–2018, 168,946 (28.4%) women in the UK were delivered by caesarean section (CS) [1].
The CS rate in the UK is increasing, with a corresponding increase in the rate of CS in the second stage
of labour [2,3]. CS at full cervical dilatation can lead to significant perinatal and maternal morbidity.
Maternal morbidity arises from an increased risk of interoperative trauma [4]. Approximately, 24% of
full dilatation CSs will sustain an extension to the uterine incision, further increasing the risk of
maternal morbidity [5].
It is estimated that 15 million neonates are born before 37 weeks’ gestation globally per annum [6].
The aetiology of preterm birth (PTB) is complex and multifactorial; however, cervical weakness is
a known risk factor in its pathogenesis. An extension to the uterine incision at full dilatation CS into
the cervix means that the cervix then undergoes structural change and remodelling as part of the
healing process. This cervical damage and repair could render the cervix weaker, so that it dilates
prematurely in a subsequent pregnancy, potentially leading to PTB.
A historical cohort study in 2015 of 878 women from the US identified that full dilatation CS
increased the risk of spontaneous PTB (sPTB) in a subsequent pregnancy in comparison to CS in the
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first stage of labour [7]. Subsequently, in 2017 a large Canadian cohort study found a significantly
increased risk of PTB in women delivered by second stage CS than those who delivered vaginally;
supporting the hypothesis that full dilatation CS increases the risk of sPTB [8]. In 2019, the UK Preterm
Clinical Network produced commissioning guidance to establish national pathways of care for women
at risk of PTB [9]. The UK network identified women with a previous delivery by CS at full dilatation
as being at intermediate risk of PTB, based on the above studies, and therefore recommend surveillance
in pregnancy in a preterm prevention clinic. However, the aforementioned studies have not accounted
for factors known to increase the risk of PTB, such as short interpregnancy interval [10] or previous
cervical treatments [11].
The aim of this study was to determine if full dilatation CS increased the risk of sPTB in a subsequent
pregnancy in comparison to CS in the first stage of labour in our unit, accounting for confounding
factors known to increase the risk of sPTB. Furthermore, we wanted to assess a dose response effect by
determining if progressively increasing cervical dilatation at the time of CS progressively increased the
risk of sPTB in a subsequent pregnancy.
2. Materials and Methods
The population of interest were women delivered by emergency CS ≥ 37 weeks’ gestation between
2008–2015 (‘the index pregnancy’), who had a subsequent pregnancy delivered ≥16 weeks’ gestation
until the end of 2015 (‘the subsequent pregnancy’). Women were retrospectively identified from the
University Hospital’s Coventry and Warwickshire local maternity system Evolution v4.0 from the
Trusts Performance and Programme Management Office in 2016. Every delivery ≥23 weeks’ gestation
is recorded in this system, immediately post-delivery. The local electronic system did not record late
miscarriages 16–23 weeks’ gestation; hence, these were searched for in the clinical record. This meant
handwritten clinical case notes and data inputted into the hospital electronic record system were then
meticulously reviewed to assess for eligibility, exposure and outcomes. There were no changes to
practice standards over the study period.
Women were excluded from the study if there was a history of previous PTB < 37 weeks’ gestation;
no documentation of gestation of previous deliveries, no documentation of the dilatation prior to
delivery or of the delivery itself; previous inclusion in the study; delivery of the subsequent pregnancy
at a different NHS Trust; index pregnancy an elective CS, intrauterine death or multiple gestation and
inability to obtain clinical notes. Women with a CS prior to the index pregnancy were eligible to be
included. Women with a previous CS were included as these are at increased risk of extensions to the
uterine incision because of scarring and thinning of the lower uterine segment following the initial CS.
During the study period, no cervical length assessment was undertaken for women in the study group.
Eligible women were divided into three groups to assess dose response as the risk of uterine
incision extension into the cervix at CS would increase with increasing cervical dilatation. The reference
group was women 0–5 cm dilated at index CS. The exposure groups were women 6–9 cm and fully
dilatated at the time of index CS.
The primary outcome was sPTB < 37 weeks’ gestation in the subsequent pregnancy.
Baseline demographics were collected for the index and subsequent pregnancy to assess for
confounding. All handwritten medical notes, operation notes and electronic documentation was
reviewed and inputted into an electronic spreadsheet. Data collected for the index pregnancy included:
age at delivery (<18, 18–34, and ≥35), ethnicity (white, black, Asian, other), body mass index at booking
(≤18.5 kg/m2, 18.6–24.9 kg/m2, 25.0–25.9 kg/m2, and ≥30 kg/m2), parity (primigravida or multigravida),
history of previous pregnancy loss between 12–24 weeks’ gestation, history of previous CS, gestation of
delivery at index pregnancy (37–38, 39–40 and 41–42), smoking status at booking, history of domestic
violence, history of illicit drug use, history of large loop excision of the transformation zone (LLETZ)
and the presence of essential hypertension, pregnancy-induced hypertension, pre-eclampsia and
gestation diabetes mellitus in the index pregnancy. Further information was collected about the
index pregnancy delivery. This included if the labour was induced, the duration of labour (defined
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as from 4 cm dilatated in the presence of regular uterine contractions until delivery of the foetal
body subdivided into 0–5 h, 6–11 h, 12–17 h, 17–23 h or ≥24 h) and the indication for the index CS
(divided into foetal distress, failure to progress in the 1st and 2nd stages of labour, failed instrumental,
not cephalic, a combination of failure to progress and foetal distress and other which includes previous
CS, sepsis and antepartum haemorrhage). Operative notes were reviewed in depth and the following
variables were recorded: the estimated blood loss at CS (mls) (subdivided into <500 mls, 500–1500 mls
and ≥1499 mls), if an extension was sustained at index CS, and the index neonate’s birthweight (kg)
(subdivided into <2.5 kg, 2.5–3.9 kg and >4 kg). An extension at CS was defined as an involuntary
tear to the uterine incision in a different direction than that intended by the surgeon. An intentional
increase in the incision length performed with scissors or a knife by the surgeon was not classified
as an extension as these are performed away from the cervix. For the subsequent delivery data was
collected and recorded for the interpregnancy interval (defined as the day of delivery to the last
menstrual period for the next pregnancy (years), subdivided into <1 and >1). The Royal College of
Obstetricians and Gynaecologists Green-top Guideline No. 45 states that an inter-delivery interval
of less than one year can increase the risk of uterine rupture [12]. Therefore, we defined a short
interpregnancy interval as being less than one year, based upon the Royal College of Obstetrics
and Gynaecology. Additionally, for the subsequent pregnancy data was collected and recorded for
the gestation of delivery (classified into <28 weeks’, 28–32 weeks’, 32–37 weeks’ and ≥37 weeks’),
indication for delivery if preterm (classified into spontaneous, preterm prelabour rupture of membranes,
iatrogenic and other) and mode of delivery.
The sample size (n = 1459) was determined after identifying women who met the study inclusion
criteria. A post hoc power calculation was then performed, prior to analysing the data. 22.6% of this
cohort were delivered by second stage CS in the exposure group. The Levine et al. cohort study found
the PTB rate in a subsequent pregnancy was 2.3% from women delivered in the first stage of labour
and 13.5% in the second stage of labour in the index pregnancy [7]. These PTB rates were entered into
power calculation, meaning that this study would have >90% power to detect a 11% difference in PTB
rate between the reference and exposure groups with a 95% confidence limit.
Data analysis was conducted in two stages using SPSS Statistics Version 24 (IBM, SPSS Statistics,
Armonk, NY, USA) and GraphPad Prism version 7.00 (GraphPad Software, La Jolle, CA, USA).
Firstly, heterogeneity was assessed between the reference and exposure groups. Normality was
assessed for continuous variables; if the data was normally distributed ANOVA was used to assess for
heterogeneity. If the data were not normally distributed, Kruskal–Wallis one-way ANOVA on ranks
was used. The chi-squared test or Fisher’s exact test was used for categorical variables, when applicable,
to assess for heterogeneity. A p value > 0.05 assumed no heterogeneity between the reference and
exposure groups.
Odds ratios (OR) with corresponding 95% confidence intervals (CI) were calculated for every
variable. The variables with the largest statistically significant odds of increasing the risk of sPTB and
those thought clinically significant (extension of the uterine incision in the index pregnancy) were
incorporated into a binary logistic regression model. OR and p values were then calculated in the
multivariable analysis. Statistical significance was set at p < 0.05.
Ethical approval was granted from the Governance Arrangements for Research and Ethics
Committee at University Hospital’s Coventry and Warwickshire on the 26 April 2016 (GR0104).
Further approval was granted from University of Warwick Biomedical and Scientific Research Ethics
Committee on the 3 August 2017 (REGO-2017-2085). The study has been reported following the
STROBE statement v4 [13].
3. Results
The initial search identified 5808 women who had an emergency CS between 2008–2015. Of these,
1459 (25.1%) went on to have a subsequent delivery until 2015. Figure 1 shows the study population.
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6.2% of the cohort had a PTB in the subsequent pregnancy, of which 64.8% were spontaneous.
The reference group consisted of 707 women (48.5%) who were 0–5 cm dilated during the index CS.
329 wo en (22.6%) were fully dilated and 423 women (29.0%) were 6–9 cm dilated during the index
CS; these were the exposure groups.
The exposure and reference groups baseline characteristics were compared to assess for
heterogeneity. This is summarised in Table 1. Further baseline characteristics can be found in
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the Supplementary Materials Table S1. There were significant differences between the groups in
ethnicity, parity, history of previous CS, gestation of delivery in index pregnancy, smoking status,
presence of gestational diabetes in the index pregnancy, if index labour was induced, the duration of
the index labour, the indication for index CS, the estimated blood loss at index CS, the presence of
extension at index CS and the birthweight of the index neonate.
Table 1. Baseline characteristics of the study population.
Cervical Dilatation at Index Caesarean Section
0–5 cm (n = 707) 6–9 cm (n = 423) Full (n = 329) p
n (%) n (%) n (%)
Age (years)
<18 11 (1.6) 5 (1.2) 5 (1.5)
0.7918–34 634 (89.7) 389 (92.0) 301 (91.5)
≥35 62 (8.8) 29 (6.9) 23 (7.0)
Ethnicity
White 423 (59.8) 286 (67.6) 244 (74.2)
<0.001
Black 120 (17.0) 57 (13.5) 21 (6.4)
Asian 140 (19.8) 59 (13.9) 49 (14.9)
Other 24 (3.4) 21 (5.0) 15 (4.6)
Body mass index
(kg/m2)
≤18.5 17 (2.4) 9 (2.1) 7 (2.1)
0.19
18.6–24.9 315 (44.6) 209 (49.9) 167 (50.8)
25.0–29.9 203 (28.8) 129 (30.5) 93 (28.3)
≥30.0 171 (24.2) 76 (18.0) 62 (18.8)
Parity Primigravida 555 (78.5) 351 (83.0) 305 (92.7) <0.001Multiparous 152 (21.5) 72 (17.0) 24 (7.3)
Previous caesarean
section
Yes 67 (9.5) 22 (5.2) 7 (2.1)
<0.001No 640 (90.5) 401 (94.8) 322 (97.9)
Gestation index
delivery (weeks’)
37–38 151 (21.4) 50 (11.8) 47 (14.3)
0.00739–40 287 (40.6) 199 (47.0) 150 (45.6)
≥41 269 (38.0) 174 (41.1) 132 (40.1)
Smoking status
Current smoker 125 (17.7) 44 (10.4) 46 (14.0)
0.003Non-smoker 582 (82.3) 379 (89.6) 283 (86.0)
Gestational diabetes in
the index pregnancy
Yes 42 (5.9) 11 (2.6) 9 (2.7)
0.01No 665 (94.1) 412 (97.4) 320 (97.3)
Induction of labour in
index pregnancy
Yes 441 (62.4) 201 (47.5) 133 (40.4)




Fetal distress 374 (52.9) 142 (33.6) 60 (18.2)
<0.001
Failure to progress 1st stage 155 (21.9) 204 (48.2) 0 (0.0)
Failure to progress 2nd stage 0 (0.0) 0 (0.0) 163 (49.5)
Failed instrumental 0 (0.0) 0 (0.0) 78 (23.7)
Not cephalic 73 (10.3) 26 (6.1) 8 (2.4)
Failure to progress and fetal
distress 45 (6.4) 38 (9.0) 14 (4.3)
Other 60 (8.5) 13 (3.1) 6 (1.8)
Extension at index
caesarean section
Yes 42 (6.2) 49 (12.4) 52 (16.8)
<0.001No 632 (93.8) 347 (87.6) 258 (83.2)
Interpregnancy
interval (years)
<1 114 (16.1) 63 (14.9) 47 (14.3)
0.71
>1 593 (83.9) 360 (85.1) 282 (85.7)
To assess for confounding odds ratios were calculated for all baseline variables believed to increase
the odds of sPTB in a subsequent pregnancy (Supplementary Table S2). A history of gestational
diabetes in the index pregnancy, estimated blood loss <500 mls at the index CS, the index pregnancy
gestation of delivery between 37–38 weeks’ gestation, a birthweight of the index infant of <2.5 kg and
an interpregnancy interval of less than one year were all found to statistically significantly increase the
odds of sPTB in the subsequent pregnancy. Therefore, these were incorporated into the binary logistic
regression model (Table 2). One hundred and forty-three (9.8%) women sustained an extension in the
index CS. The sustainment of an extension at index CS did not significantly increase the odds of sPTB
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in a subsequent pregnancy in the unadjusted (OR 1.11; 95% CI 0.47–2.64; p 0.82) and adjusted analysis
(OR 1.34; 95% CI 0.54–3.29; p 0.53) (Table 2). Even though this did not significantly increase the odds of
sPTB in the subsequent pregnancy, this was included into the binary logistic regression modelling
as it was clinically significant. In this cohort smoking, maternal age, history of domestic violence
and history of drug use did not significantly increase the risk of sPTB in the subsequent pregnancy
(Supplementary Materials Table S2).
Table 2. Odds ratio for all baseline variables found to increase the risk of spontaneous preterm birth
in a subsequent pregnancy. sPTB: spontaneous preterm birth; CS: caesarean section; OR: odds ratio;






Gestation OR (95% CI)





39–42 37 1174 1.00 -






No 53 1344 1.00 -




loss at index CS
(mls)
≥500 29 956 1.00 -





No 47 1190 1.00 -






≥2.5 52 1353 1.00 -





>1 39 1196 1.00 -
<1 20 204 3.01(1.72–5.26) <0.001
3.10
(1.71–5.61) <0.001
* Fishers Exact test.
Fifty-nine women (4.0%) had a sPTB in their subsequent delivery. The sPTB rate in a subsequent
pregnancy was 3.5%, 4.0% and 5.2% for the reference, 6–9 cm dilatated and fully dilated at index CS
groups (p 0.46). In comparison to the reference group, being 6–9 cm or fully dilated at index CS did not
significantly increase the risk of spontaneous PTB < 37 weeks’ gestation in a subsequent pregnancy OR
1.14 (95% CI 0.62–2.08; p 0.68) and OR 1.49 (95% CI 0.80–2.72; p 0.22) respectively in the unadjusted
analysis (Table 3). After adjusting for potential confounders, the risk of sPTB in a subsequent pregnancy
after an emergency CS increased but did not reach statistical significance (6–9 cm: OR 1.64; 95% CI
0.83–3.28; p 0.158 and full dilatation: OR 1.86; 95% CI 0.91–3.83; p 0.090).
There were no statistically significant differences between the exposure and reference groups in
the odds of sPTB at <28 and <32 weeks’ gestation (Table 3).
To further assess the risk of increasing cervical dilatation at emergency CS on sPTB in a subsequent
pregnancy, binary logistic regression modelling was undertaken. For each 1 cm of cervical dilatation
gained at the index CS the odds of subsequent sPTB in a subsequent pregnancy increased by 2%, but the
relationship did not reach statistical significance (OR 1.02; 95% CI 0.94–1.11; p 0.65). After adjusting for
confounding the odds of sPTB for each centimetre of cervical dilatation increased but did not reach
statistical significance (aOR 1.08; 95% CI 0.99–1.18; p 0.11).
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Table 3. Risk of spontaneous preterm birth in a subsequent pregnancy at <28, <32 and <37 weeks’
gestation following an emergency caesarean section at 0–5, 6–9 of full cervical dilatation.
n (%) OR (95% CI) p aOR (95%CI) p
<28 weeks’
gestation
0–5 cm dilated at index CS 3 (0.42) 1.00 (ref) 1.00 (ref)
6–9 cm dilated at CS 3 (0.71) 1.68* (0.34–8.35) 0.68 1.81 (0.33–10.01) 0.5
Fully dilated at index CS 2 (0.61) 1.44* (0.25–8.64) 0.66 0.78 (0.07–8.11) 0.83
<32 weeks’
gestation
0–5 cm dilated at index CS 7 (0.99) 1.00 (Ref) 1.00 (ref)
6–9 cm dilated at CS 4 (0.95) 0.95 * (0.28–3.28) >0.99 1.11 (0.31–4.00) 0.87
Fully dilated at index CS 5 (1.52) 1.54* (0.49–4.90) 0.53 1.40 (0.39–5.03) 0.61
<37 weeks’
gestation
0–5 cm dilated at index CS 25 (3.54) 1.00 (ref) 1.00 (ref)
6–9 cm dilated at CS 17 (4.02) 1.14 (0.62–2.08) 0.68 1.64 (0.83–3.28) 0.16
Fully dilated at index CS 17 (5.17) 1.49 (0.80–2.72) 0.22 1.86 (0.91–3.83) 0.09
* Fishers Exact test.
A surprise finding was that despite the fact that in the UK women are advised not to conceive
again within a year after a CS, there was an increased risk of sPTB following an emergency CS with
a short interpregnancy interval. Therefore, a secondary analysis on the effect of short interpregnancy
interval following an emergency CS was undertaken. The adjusted OR for sPTB after an emergency CS
with an interpregnancy interval <1 year was 3.01 (95% CI 1.72–5.26; p < 0.000). For each 6 months
increment in interpregnancy interval the odds of sPTB decreased; however, this did not reach statistical
significance in the unadjusted and adjusted analysis (OR 0.90; 95% CI 0.81–1.01; p 0.75 and aOR 0.91;
95% CI 0.80–1.02; p 0.11, respectively).
4. Discussion
This study’s aim was to determine if full dilatation CS increased the risk of sPTB in a subsequent
pregnancy in comparison to CS in the first stage of labour in our unit, while accounting for confounding
factors known to increase the risk of sPTB. Furthermore, we wanted to determine if increasing cervical
dilatation at the time of CS increased the risk of sPTB in a subsequent pregnancy.
Full dilatation CS has been associated with increased risk of sPTB in a subsequent pregnancy.
During full dilatation CS there is an increased risk of extension of the hysterotomy incision into the
cervix [4,5]. Furthermore, when the cervix is incorporated into the lower segment, a low hysterotomy
incision could inadvertently cross the cervix, or the cervix could be brought into the hysterotomy
closure. This could lead to the loss of the cervix’s structural integrity making it weak in a future
pregnancy. The concept of surgery leading to cervical weakness is supported by the evidence that
previous cervical treatments increase the risk of PTB in subsequent pregnancies, secondary to cervical
weakness [11,14].
We found that CS performed at 6–9 cm dilated and fully dilated did increase the risk of sPTB < 37
weeks’ gestation in a subsequent pregnancy, however the relationship did not reach statistical
significance. CS at 6–9 cm and full cervical dilatation did not increase the risk of sPTB < 28 and
<32 weeks’ gestation in a subsequent pregnancy. Therefore, our hypothesis that increasing cervical
dilatation at CS increases the risk of sPTB in a subsequent pregnancy was not supported.
Our results differ from other studies that have been published which do show a significant
association between full dilatation CS and subsequent PTB. In 2015 Levine et al. found 6-fold higher
odds of sPTB when CS was performed in the second stage in comparison to the first stage of labour,
a relationship which remained after adjusting for race, chronic hypertension, induction of labour,
but not short interpregnancy interval [7]. Following this a large Canadian retrospective cohort study of
189,021 women found an increased risk of sPTB < 37 weeks’ gestation in a subsequent pregnancy when
CS was performed in the second stage of labour in comparison to vaginal delivery [8]. The risk of
subsequent delivery <32 weeks’ gestation was greater in their analysis, that accounted for body mass
index and smoking but not short interpregnancy interval. A third large retrospective cohort study of
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2675 women from Australia found that full dilatation CS doubled the odds of sPTB in a subsequent
pregnancy in comparison to CS in the first stage of labour [15].
The current study found a non-statistically significant increase in the risk of sPTB in a subsequent
pregnancy after a full dilatation CS in comparison to a CS in the first stage of labour. The current
study was powered to detect a difference in the sPTB rate of 2.3–13.5% between first and second stage
CS but found a difference of 2.3–5.3%. Therefore, the study was underpowered to detect a small
increase in PTB with full dilatation CS. Our results may also differ to other published results as we have
adjusted for short interpregnancy interval. In this study, the logistic regression analysis found short
inter-pregnancy interval of <1 year increased the risk of sPTB more than full dilatation at index CS or
extension of uterine incision. This may account for the differences seen in our study to other published
results. Furthermore, we have included multiparous women in the analysis, as did the Levine et al.
cohort [7], whereas the other cohorts have included nulliparous women [8,15]. A total of 17.6% of this
cohort were multiparous, and 0.07% of women in the cohort had a CS prior to the index pregnancy.
A weakness of this study is that we do not know the dilatation of the CS prior to the index pregnancy,
which could confound results. However, the numbers of women with a previous CS were low and we
did not find that CS prior to the index pregnancy increased the risk of sPTB in the follow up pregnancy.
Additionally, we found in the logistic regression analysis that index CS performed at 37–38 weeks’
gestation significantly was associated with an increased the risk of sPTB in a subsequent pregnancy in
comparison to CS at 39–42 weeks’ gestation. Even though women with an elective CS were excluded
from this study, this finding may be important with regards to timing of elective procedures and the
risk on future pregnancies. However, it is difficult to draw conclusions around this as the study was not
powered to look at time of delivery and risk of sPTB in a subsequent pregnancy and time of delivery
should be carefully balances upon the risks posed to that pregnancy. In this population, an estimated
blood loss of <500 mls at the index CS was associated with an increased risk of sPTB in the subsequent
pregnancy. It is difficult to ascertain the clinical significance of this finding as blood loss at CS is often
inaccurate and this finding could be due to chance. We have theorised that these women may have
increased myometrial sensitivity to agonists, leading to an improved tonic contraction of the uterus to
prevent haemorrhage and earlier activation of parturition pathways [16].
The major strength of this study was the comprehensive data collection, vigorous exclusion
criteria, and categorisation of the variables. For all women included in the study, clinical notes and
operative notes were reviewed thoroughly in detail to determine the reliability of the data and to assess
for all variables that could confound PTB rates. Furthermore, the data all originated from one hospital
trust, therefore decreasing variation in clinical practice across units.
The first limitation was described above, detailing how this study was underpowered to detect
a small difference in outcome. Another limitation is that the electronic hospital information system
used is only able to capture deliveries >22 weeks’ gestation. Women with a late miscarriage would not
have been captured in the analysis. A case control study from 2017 found that CS at full dilatation
increased the risk of late miscarriage and sPTB [17]. The increase in late miscarriages would not have
been detected.
A surprise finding from this study was that a short interpregnancy interval of less than 1 year
had a greater impact upon the risk of sPTB in a subsequent pregnancy than full dilatation CS in
the logistic regression analysis. Previous work has also demonstrated that a short interpregnancy
interval increases the risk of sPTB in a subsequent pregnancy [10]. This has been hypothesised as being
secondary to maternal nutritional depletion and postpartum stress [18]. However, further work is
required to determine if the sPTB rate differs for women with a short interpregnancy interval who
were delivered vaginally or by CS.
The current data adds to the emerging literature associating previous CS with sPTB. In 2019 the
UK Preterm Clinical Network produced commissioning guidance to establish national pathways of
care for women at risk of PTB [9]. They have identified women with a previous delivery by CS at full
dilatation as being at intermediate risk of PTB and therefore recommend surveillance in pregnancy in
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a preterm prevention clinic. Further to this in 2019 NHS England released the ‘Saving Babies’ Lives
Version Two’ Care Bundle in which women with a history of full dilatation CS was also deemed being
an intermediate risk for the development of PTB [19]. Based on the published literature and national
care pathways, we would recommend that women with a previous full dilatation CS are referred for
increased surveillance in their pregnancy. However, we also recommend that women with a short
interpregnancy interval after a CS should also be considered for referral to preterm prevention services
to decrease the risk of sPTB. We would advise emphasis on postnatal contraception after caesarean to
prevent pregnancies with a short interpregnancy interval.
5. Conclusions
The current study of our population found that full dilatation CS did not significantly increase the
risk of sPTB in a subsequent pregnancy. We found that a short interpregnancy interval following CS
increased the risk of sPTB more than a full dilatation CS. Clinically, this is important as improving
counselling about postnatal contraception following a CS and increased surveillance in women with
a short interpregnancy interval may be effective strategies to reduce PTB. Further prospective studies
are required to confirm our findings in other populations and are current recruiting [20].
Supplementary Materials: The following are available online at http://www.mdpi.com/2077-0383/9/12/3998/s1,
Table S1: Additional baseline characteristics of the study population, Table S2: Odds ratio for all baseline variables
thought to increase the risk of spontaneous preterm birth in a subsequent pregnancy.
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